January 24, 2024
Author: Dr. Jessica Staples
Can Generic Restasis Treat Chronic Dry Eye Disease?
Breaking news in dry eye disease treatment, the U.S. Food and Drug Administration (FDA) has approved the first generic version of Restasis, cyclosporine ophthalmic emulsion 0.05%. This milestone, headed by Mylan Pharmaceuticals Inc., is poised to redefine the landscape of dry eye treatment. ...